NCT01235936View on ClinicalTrials.gov

Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 21, 2010

Primary Completion Date

April 13, 2011

Study Completion Date

May 31, 2011

Conditions
AnemiaKidney Disease
Interventions
DRUG

AKB-6548

Different dose levels

Trial Locations (2)

Unknown

Augusta

San Antonio

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY

NCT01235936 - Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia | Biotech Hunter | Biotech Hunter